Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Durata Therapeutics
Durata Therapeutics is a clinical development stage biopharmaceutical company.
Sector
Subsector
Keywords
Location
total rounds
total raised
Verona Pharma
Verona Pharma is a clinical-stage biopharmaceutical company that develops innovative therapies for chronic respiratory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
PhaseBio Pharmaceuticals
PhaseBio develops drugs for endocrine disorders, cardiovascular disease, and orphan diseases.
Sector
Subsector
Location
total rounds
total raised
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for cancer and other major diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 21.10.2022. Their latest investor European Innovation Council. Their latest round Grant
European Innovation Council
The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
European Innovation Council
The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors3
Number of lead investors
Number of investors
European Innovation Council
The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Enterprise Ireland
Enterprise Ireland is a government agency that funds and develops Irish businesses to achieve strong positions in global markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Sean McKeown
current job
EASME - EU Executive Agency for SMEs
EASME manages EU programs for SMEs, environment, energy, and maritime projects.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Therese Kinsella
Therese Kinsella is Professor of Biochemistry within the School of Biomolecular and Biomedical Sciences, UCD. She is a leading expert in the field of prostanoid biology, focusing on the vasculature and has published extensively in this area in top journals and book chapters. Therese has patent-protected her work, including in the discovery and development of TP antagonists. She has also acted as expert consultant to large pharmaceutical, biotech & life science venture capital funds. In recognition of her contribution to her research field, she has received a number of awards during her professional career including; Royal Irish Academy Medal in Biochemistry (2000); Elected Member Royal Irish Academy (MRIA, 2006); Biochemical Society (IAS) Gold Medal (2008). She has extensive expertise in securing research funding and in grant management and has, for example, held a prestigious WT program grant and several WT project grants. She has secured three successive commercialization-type grants: Enterprise Ireland and Science Foundation Ireland, enabling the drug-discovery/development from target identification; generation and characterization of novel TP antagonists, including ATXA's lead drug, NTP42 ; development and prioritization of target market. Having begun her research career in industry (Guinness), she has a strong appreciation of the underlying processes of product/drug development, including associated challenges.
current job
organization founded
Therese Kinsella
Daniel O' Mahony
Daniel O’ Mahony has 26 years international experience at a senior level of management in industry and scientific research, ten years of which were at Elan Corporation where he held the positions of VP Technology & Asset Divestment and VP Experimental Biology followed by R&D Director at Taro Pharmaceuticals. He has held academic posts at the Biochemistry Department, University College Cork; the Genetics Department, Trinity College, Dublin; The Weis Research Centre, PA, USA; the Department of Medicine & Experimental Therapeutics, University College Dublin and the Mater Hospital Centre for Cardiovascular Science. He established the very successful Technology Transfer Office at the National University Ireland, Galway in 2005. His skills encompass major aspects of biopharmaceutical and biotechnology industries, technology licensing from university sector and campus company formation. He is a named inventor on 25 patents, author of over 40 publications and presenter and speaker at numerous international conferences. He sits on the board of a number of private companies. He holds a Ph.D in biochemistry and molecular genetics from University College Cork and a business degree in technology management from the Smurfit business school, University College Dublin. He has been a member of Kernel Capital Advisory board since 2002 and since then he has lead over 25 comprehensive due diligence reviews on behalf of the firm. He commenced a full time position with Kernel as a Partner in January 2008.
current job
organization founded
Daniel O' Mahony
Employee Profiles3
Therese Kinsella
Founder and Chief Scientific Officer